Thom Gunderson
Thom Gunderson
box key penalty products
This is one of their key new products in pre-market approval, and here they've been put into the penalty box for PMA approvals.
fund quite
They've got quite the bankroll to fund that.
boston couple good looks scientific similar smart
Again, it looks like it's too expensive. Looks like it's a little too much. It's good for the Guidant shareholders. But we'll see in a couple of years. I think it will play out similar to history, and that is Boston Scientific will look pretty smart here.
boston challenge comfort normal outside paying premium present scientific
Under normal circumstances, this would present a challenge for Boston Scientific because they're already outside their normal comfort zone. But now you're doing something unusual: You're paying a premium for something that's broken.